Different bleeding risk in type 2A and 2M von Willebrand disease: a 2‐year prospective study in 107 patients: a rebuttal

To cite this article: Favaloro EJ, Bonar R, Marsden K. Different bleeding risk in type 2A and 2M von Willebrand disease: a 2‐year prospective study in 107 patients: a rebuttal. J Thromb Haemost 2012; 10: 1455–8.See also Castaman G, Baronciani L, Canciani MT, Federici AB. Different bleeding risk in type 2A and 2M von Willebrand disease: a 2‐year prospective study in 107 patients: a reply to a rebuttal. This issue, pp 1458–60.

[1]  G. Castaman,et al.  Different bleeding risk in type 2A and 2M von Willebrand disease: a 2‐year prospective study in 107 patients: a reply to a rebuttal , 2012 .

[2]  E. Favaloro,et al.  Differential sensitivity of von Willebrand factor (VWF) ‘activity’ assays to large and small VWF molecular weight forms: a cross‐laboratory study comparing ristocetin cofactor, collagen‐binding and mAb‐based assays , 2012, Journal of thrombosis and haemostasis : JTH.

[3]  P. Mannucci,et al.  Different bleeding risk in type 2A and 2M von Willebrand disease: a 2‐year prospective study in 107 patients , 2012, Journal of thrombosis and haemostasis : JTH.

[4]  C. Forsyth,et al.  Distinguishing types 1 and 2M von Willebrand disease , 2012, International journal of laboratory hematology.

[5]  E. Favaloro,et al.  von Willebrand Disease: Local Diagnosis and Management of a Globally Distributed Bleeding Disorder , 2011, Seminars in thrombosis and hemostasis.

[6]  W. Chandler,et al.  Von Willebrand factor assay proficiency testing. The North American Specialized Coagulation Laboratory Association experience. , 2011, American journal of clinical pathology.

[7]  E. Favaloro,et al.  Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays? , 2009, Thrombosis research.

[8]  P. Mannucci,et al.  Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor , 2006, Journal of thrombosis and haemostasis : JTH.

[9]  P. Mannucci,et al.  von Willebrand factor collagen binding assay in von Willebrand disease type 2A, 2B, and 2M , 2006, Journal of thrombosis and haemostasis : JTH.

[10]  A. Street,et al.  Reducing errors in identification of von Willebrand disease: the experience of the royal college of pathologists of australasia quality assurance program. , 2006, Seminars in thrombosis and hemostasis.

[11]  F. Haverkate,et al.  An external quality assessment program for von Willebrand factor laboratory analysis: an overview from the European concerted action on thrombosis and disabilities foundation. , 2006, Seminars in thrombosis and hemostasis.